X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11833) 11833
Book Review (1172) 1172
Publication (983) 983
Book Chapter (15) 15
Conference Proceeding (13) 13
Newspaper Article (12) 12
Book / eBook (9) 9
Government Document (8) 8
Dissertation (3) 3
Data Set (2) 2
Magazine Article (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11393) 11393
index medicus (11336) 11336
prospective studies (10182) 10182
female (8878) 8878
male (8135) 8135
middle aged (7881) 7881
aged (6746) 6746
adult (6133) 6133
oncology (5159) 5159
treatment outcome (3907) 3907
cancer (2808) 2808
chemotherapy (2670) 2670
aged, 80 and over (2520) 2520
antineoplastic combined chemotherapy protocols - therapeutic use (2207) 2207
follow-up studies (1996) 1996
care and treatment (1861) 1861
surgery (1845) 1845
prognosis (1618) 1618
neoplasm staging (1495) 1495
medicine & public health (1489) 1489
survival rate (1463) 1463
radiotherapy (1462) 1462
adolescent (1419) 1419
research (1382) 1382
therapy (1360) 1360
abridged index medicus (1339) 1339
disease-free survival (1336) 1336
analysis (1255) 1255
young adult (1234) 1234
survival (1172) 1172
risk factors (1125) 1125
combined modality therapy (1121) 1121
clinical trials (1109) 1109
time factors (1091) 1091
survival analysis (1053) 1053
trial (1013) 1013
health aspects (1012) 1012
radiology, nuclear medicine & medical imaging (981) 981
antineoplastic combined chemotherapy protocols - adverse effects (974) 974
carcinoma (952) 952
drug administration schedule (938) 938
hematology (923) 923
phase-ii (913) 913
hematology, oncology and palliative medicine (900) 900
antineoplastic agents - therapeutic use (832) 832
patients (786) 786
cisplatin (733) 733
quality of life (717) 717
radiation-therapy (711) 711
cisplatin - administration & dosage (698) 698
tumors (666) 666
child (662) 662
metastasis (654) 654
drug therapy (639) 639
dose-response relationship, drug (637) 637
pharmacology & pharmacy (636) 636
toxicity (620) 620
fluorouracil - administration & dosage (614) 614
double-blind method (610) 610
phase-ii trial (610) 610
disease progression (609) 609
mortality (594) 594
retrospective studies (594) 594
breast cancer (592) 592
antineoplastic combined chemotherapy protocols - administration & dosage (590) 590
medical research (589) 589
breast neoplasms - drug therapy (575) 575
management (553) 553
chemotherapy, adjuvant (532) 532
radiotherapy dosage (532) 532
prospective randomized-trial (525) 525
diagnosis (513) 513
article (512) 512
radiation (511) 511
efficacy (504) 504
transplantation (504) 504
lung neoplasms - drug therapy (501) 501
oncology, experimental (500) 500
clinical neurology (499) 499
cohort studies (497) 497
kaplan-meier estimate (494) 494
feasibility studies (492) 492
safety (488) 488
medicine (485) 485
patient outcomes (480) 480
risk (470) 470
breast neoplasms - pathology (457) 457
usage (457) 457
cardiac & cardiovascular systems (451) 451
pilot projects (451) 451
recurrence (448) 448
child, preschool (446) 446
deoxycytidine - analogs & derivatives (443) 443
lung neoplasms - pathology (443) 443
antineoplastic agents - administration & dosage (441) 441
medicine, experimental (436) 436
gastroenterology & hepatology (430) 430
fluorouracil (428) 428
neoplasm metastasis (423) 423
cancer research (417) 417
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11685) 11685
French (62) 62
German (54) 54
Chinese (19) 19
Spanish (19) 19
Japanese (13) 13
Italian (8) 8
Hungarian (6) 6
Russian (4) 4
Portuguese (3) 3
Turkish (3) 3
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2009, Volume 15, Issue 4, pp. 1452 - 1459
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 12, pp. 2051 - 2057
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2011, Volume 29, Issue 2, pp. 142 - 148
Journal Article
European heart journal, ISSN 0195-668X, 2011, Volume 32, Issue 22, pp. 2781 - 2789
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2015, Volume 128, Issue 12, pp. 1306 - 1313.e1
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 11/2011, Volume 9, Issue 1, pp. 204 - 204
Background: Ipilimumab, a fully human monoclonal antibody that blocks cytotoxic T-lymphocyte antigen-4, has demonstrated an improvement in overall survival in... 
Tumor biomarker | Cytotoxic t-lymphocyte antigen-4 | Tumor-infiltrating lymphocytes | Ipilimumab | Melanoma | Indoleamine 2,3-dioxygenase | Foxp3 | MEDICINE, RESEARCH & EXPERIMENTAL | CTLA-4 BLOCKADE | INFILTRATING LYMPHOCYTES | Cytotoxic T-lymphocyte antigen-4 | melanoma | PERIPHERAL-BLOOD | OVARIAN-CARCINOMA | BREAST-CANCER | PROGNOSTIC-FACTOR | COLORECTAL-CANCER | ipilimumab | REGULATORY T-CELLS | tumor-infiltrating lymphocytes | indoleamine 2,3-dioxygenase | FoxP3 | tumor biomarker | ABSOLUTE LYMPHOCYTE COUNT | Immunohistochemistry | Prospective Studies | Skin Neoplasms - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | RNA, Messenger - metabolism | Dose-Response Relationship, Drug | Young Adult | Antineoplastic Agents - adverse effects | Melanoma - genetics | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Skin Neoplasms - pathology | Tumor Microenvironment - drug effects | Drug Administration Schedule | Antibodies, Monoclonal - pharmacology | RNA, Messenger - genetics | Treatment Outcome | Melanoma - pathology | Polymorphism, Genetic | Antibodies, Monoclonal - administration & dosage | Melanoma - drug therapy | Skin Neoplasms - genetics | Aged | Neoplasm Staging | Usage | Messenger RNA | Physiological aspects | Genetic aspects | Research | Biological markers | Gene expression | Studies | Clinical trials | Medical research | Cancer | Index Medicus
Journal Article